| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.5 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.5 |